Michael McClellan
2018
In 2018, Michael McClellan earned a total compensation of $4.9M as Executive Vice President, Chief Financial Officer at Teva Pharmaceutical Industries, a 353% increase compared to previous year.
Compensation breakdown
| Bonus | $135,000 |
|---|---|
| Non-Equity Incentive Plan | $1,172,640 |
| Option Awards | $900,003 |
| Salary | $700,000 |
| Stock Awards | $1,799,992 |
| Other | $238,375 |
| Total | $4,946,010 |
McClellan received $1.8M in stock awards, accounting for 36% of the total pay in 2018.
McClellan also received $135K in bonus, $1.2M in non-equity incentive plan, $900K in option awards, $700K in salary and $238.4K in other compensation.
Rankings
In 2018, Michael McClellan's compensation ranked 2,047th out of 14,244 executives tracked by ExecPay. In other words, McClellan earned more than 85.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,047 out of 14,244 | 86th |
Division Manufacturing | 735 out of 5,765 | 87th |
Major group Chemicals And Allied Products | 244 out of 2,128 | 89th |
Industry group Drugs | 195 out of 1,817 | 89th |
Industry Pharmaceutical Preparations | 151 out of 1,391 | 89th |
Source: SEC filing on April 16, 2019.
McClellan's colleagues
We found four more compensation records of executives who worked with Michael McClellan at Teva Pharmaceutical Industries in 2018.
2018
Kåre Schultz
Teva Pharmaceutical Industries
Chief Executive Officer
2018
Carlo de Notaristefani
Teva Pharmaceutical Industries
Executive Vice President, Global Operations
2018
Hafrun Fridriksdottir
Teva Pharmaceutical Industries
Executive Vice President, Global Research and Development
2018
Mark Sabag
Teva Pharmaceutical Industries